(Alliance News) - Remote Monitored Systems PLC on Thursday said its subsidiary Pharm 2 Farm Ltd is expected to begin commercial production of its anti-viral face mask line in January.
Remote Monitored shares were 27% lower at 1.87 pence each in London on Thursday morning but are more than five-times higher than they were at the end of 2019.
The data collection and surveying firm said Pharm 2 Farm was told on Wednesday by manufacturers that production machinery for the masks will undergo final acceptance next month in Spain.
"It will then be shipped, installed and commissioned at P2F's Biocity premises in Nottingham. Commercial production and shipment of product is now expected to begin in January 2021," Remote said.
Back in November 11, shortly after promising news of interim trial results from Pfizer Inc and BioNTech SE's Covid-19 vaccine candidate, Remote said its unit was looking to bring the mask to market "as soon as possible". It also added positive news on the vaccine does not lessen demand for the viricidal mask product.
By Eric Cunha; ericcunha@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.
